Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study (Q73599577)
scientific article published on 01 April 2000
Language:
(P31) (Q13442814)
(P50) (Q71745710)
(P304) 624-631
(P407) (Q1860)
(P433) 4
(P478) 139
(P577) Saturday, April 1, 2000
(P921) (Q496359)
(P1433) (Q2227156)
(P1476) "Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study" (language: en)
(P2093) M Echemann
F Zannad
S Briançon
Y Juillière
P M Mertès
J P Villemot
(P2860) (Q67959929)
(Q39461053)
(Q34682919)
(Q34620874)
(Q33611888)
(Q40470495)
(Q34539986)
(Q60164685)
(Q34718800)
(Q41442464)
(Q35258655)
(Q41009592)
(Q41064380)
(Q71724578)
(Q41016284)
(Q57259676)
(Q57631093)
(Q53593952)
(Q72932823)
(Q39465974)
(Q73739605)
(Q50856196)
(Q74152423)
(Q73940052)
(Q45072710)
(Q53556372)
(Q73175222)
(Q41584864)
(Q46442169)
(Q71193550)
(Q40869794)
(Q54249551)
(Q71720357)
(Q28372091)
(Q40960590)
(Q57396411)
other details
description scientific article published on 01 April 2000

External Links